DCF — CARRIS HEALTH
Enterprise Value: $-50.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-50.0M
Enterprise Value
$-19.6M
PV of Cash Flows
$-30.4M
PV of Terminal Value
$-49.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $144.6M | $-1.0M | -1.0% | $-7.2M | $-6.5M |
| Year 2 | $148.9M | $0.4M | 0.0% | $-5.9M | $-4.9M |
| Year 3 | $153.4M | $2.0M | 1.0% | $-4.5M | $-3.4M |
| Year 4 | $158.0M | $2.8M | 2.0% | $-3.9M | $-2.6M |
| Year 5 | $162.8M | $3.3M | 2.0% | $-3.6M | $-2.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-50.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$140.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.012181313884956897
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5